Human papillomavirus infection: the efficacy of treatment with inosine pranobex


Cite item

Full Text

Abstract

The high frequency of the spread of human papillomavirus and a high risk of recurrence associated diseases require the search for effective therapies. The analysis of quality clinical trials showed data on the efficacy, tolerability of treatment. Our study demonstrates higher efficiency destructive methods in conjunction with the system using Isoprinosine. Even Isoprinosine mono therapy's efficiency reaches 68%.

About the authors

P V Budanov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: pbumer@mail.ru
д-р мед. наук, проф. каф. акушерства, гинекологии и перинатологии лечебного фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

A A Churganova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

канд. мед. наук, ассистент каф. акушерства, гинекологии и перинатологии лечебного фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

K R Bakhtiyarov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

д-р мед. наук, проф. каф. акушерства, гинекологии и перинатологии лечебного фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

A N Strizhakov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

д-р мед. наук, проф., акад. РАН, зав. каф. акушерства, гинекологии и перинатологии лечебного фак-та ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

References

  1. Прилепская В.Н., Рудакова Е.Б. Генитальные инфекции и патология шейки матки. Клинические лекции. Омск: ИПЦ ОмГМА, 2004.
  2. Прилепская В.Н. Заболевания шейки матки, влагалища и вульвы. М.: МЕДпресс - информ, 2005.
  3. Прилепская В.Н. Вирус папилломы человека: современный взгляд на проблему. Мед. вестн. 2007; 29 (414): 9-10.
  4. Рудакова Е.Б. Псевдоэрозии шейки матки. Автореф. дис. … д - ра мед. наук. Омск, 1996.
  5. Роговская С.И., Прилепская В.Н. Оптимизация лечения хронических цервицитов с помощью изопринозина. Гинекология. 2006; 8 (1): 4-7.
  6. Chen J.N, Chen L.D, Zhang W.Y et al. Epidemiological survey of high - risk human papillomavirus among 2501 woman. Nan Fang Yi Ke Da Xue Xue Bao 2015; 35 (10): 1487-91.
  7. Cheng J, Bian M, Cong X et al. Evaluation of a novel real - time fluorescent polymerase chain reaction assay for high - risk human papilloma virus DNA genotypes in cytological cervical screening. Biomed Rep 2013; 1 (2): 280-4.
  8. Globocan. Cancer incidence, mortality and prevalence world wide. Last access 25.01.2007.IARC WHU Press Release 151 IARC confirms efficacy of cervix cancer screening for women 25-65 in reducing mortality, 03 May 2004.
  9. Donders G, Parent D. HPV. Questions & Answers. Benign genital HPV infections. Int. Edition. Artoos Communicatie group NV 2010.
  10. Nejmark B.A, Kondrat'eva J.S, Zologina V.S, Torbik D.V. Effectiveness of combined treatment of HPV infection. Urologiia 2015; 2: 39-40, 42.
  11. Parkin D.M, Bray F. The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl. 3): 11-25.
  12. Rintala M.A, Grenman S.E, Jarvenkyla M.E et al. High - risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 2005; 41: 1728-33.
  13. Virtanen A, Anttila A, Nieminen P. The costs of offering HPV-testing on self - taken samples to non - attendees of cervical screening in Finland. BMC Womens Health 2015; 15 (1): 99.
  14. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization, 2013.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).